Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2025-10-29 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled as an "Investor Relations Management System" for a company, detailing principles, content, communication methods, organizational responsibilities, and compliance related to investor relations management. It does not contain financial statements, earnings data, audit results, or any reportable financial performance metrics. It is a governance-related document outlining internal rules and procedures for managing investor relations and communication. The document length is 2679 characters, which is relatively short and more consistent with a policy or governance document rather than a full report. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-10-29 Chinese
董事会战略委员会议事规则
Governance Information Classification · 95% confidence The document is titled as the 'Board Strategic Committee Meeting Rules' of a company, detailing the composition, responsibilities, meeting procedures, and governance related to the board's strategic committee. It references company law, securities law, governance codes, and ESG (Environmental, Social, and Governance) matters. The content is about internal governance rules and committee operations rather than financial results, audit, or shareholder voting. It is not a report of financial performance, audit, or meeting results, nor is it a presentation or announcement. It fits the category of Governance Information, which covers internal rules, board structure, and governance practices.
2025-10-29 Chinese
董事会审计委员会议事规则
Governance Information Classification · 95% confidence The document is titled '董事会审计委员会议事规则' which translates to 'Board Audit Committee Meeting Rules'. It outlines the structure, responsibilities, and procedures of the audit committee under the board of directors. The content focuses on governance, audit oversight, and internal control monitoring, rather than presenting financial data or audit results. It is a governance-related document detailing internal rules and committee functions, not an audit report or financial statement. Therefore, it fits best under Governance Information (CGR). The document length is 2985 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full financial report.
2025-10-29 Chinese
董事会薪酬与考核委员会议事规则
Governance Information Classification · 95% confidence The document is titled as the "Board of Directors Remuneration and Assessment Committee Rules" of a company. It details the structure, responsibilities, and procedures of the remuneration and assessment committee under the board of directors. The content focuses on governance practices related to board and senior management compensation and performance evaluation. There are no financial statements, earnings data, or regulatory filings. The document is a governance-related internal rules report, not an announcement or a financial report. Therefore, it fits the category of Governance Information (CGR). The document length is 2091 characters, which is relatively short but contains substantive governance content, not just an announcement.
2025-10-29 Chinese
马应龙关于取消监事会并修订《公司章程》及修订、制定部分治理制度的公告
Governance Information Classification · 95% confidence The document is a detailed announcement from the board of directors of 马应龙药业集团股份有限公司 regarding the cancellation of the supervisory board and the revision of the company's articles of association and governance systems. It includes extensive text about corporate governance rules, shareholder rights, board responsibilities, and procedural changes. The content focuses on governance structure and internal company rules rather than financial results, audit opinions, or legal proceedings. It is not a full annual report, interim report, or earnings release. It is not a simple announcement of voting results or a proxy solicitation. The document is a governance-related announcement detailing changes to the company's governance documents and internal rules, consistent with the category of Governance Information (CGR). The document length and detail confirm it is not a brief announcement or a report publication notice. Therefore, the most appropriate classification is Governance Information (CGR).
2025-10-29 Chinese
马应龙2025年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a '2025 年半年度报告摘要' which translates to '2025 Half-Year Report Summary' for 马应龙药业集团股份有限公司. It contains detailed financial data for the half-year period, including total assets, net profit, revenue, earnings per share, and shareholder information. The document also includes a management discussion and analysis section about the company's operating environment, business segments, and strategic initiatives during the half-year period. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length is 4495 characters, which is sufficient to contain substantive financial data and analysis, not just an announcement or summary. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). H1 2025
2025-08-28 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.